Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adma Biologics (ADMA) Operating Leases: 2020-2025

Historic Operating Leases for Adma Biologics (ADMA) over the last 5 years, with Sep 2025 value amounting to $9.4 million.

  • Adma Biologics' Operating Leases rose 6.00% to $9.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.4 million, marking a year-over-year increase of 6.00%. This contributed to the annual value of $8.6 million for FY2024, which is 12.46% down from last year.
  • Latest data reveals that Adma Biologics reported Operating Leases of $9.4 million as of Q3 2025, which was up 1.03% from $9.3 million recorded in Q2 2025.
  • In the past 5 years, Adma Biologics' Operating Leases registered a high of $10.9 million during Q2 2022, and its lowest value of $7.3 million during Q1 2022.
  • Its 3-year average for Operating Leases is $9.4 million, with a median of $9.4 million in 2025.
  • Its Operating Leases has fluctuated over the past 5 years, first soared by 72.18% in 2021, then decreased by 12.53% in 2025.
  • Adma Biologics' Operating Leases (Quarterly) stood at $7.5 million in 2021, then surged by 43.44% to $10.7 million in 2022, then decreased by 8.64% to $9.8 million in 2023, then fell by 12.46% to $8.6 million in 2024, then rose by 6.00% to $9.4 million in 2025.
  • Its Operating Leases was $9.4 million in Q3 2025, compared to $9.3 million in Q2 2025 and $8.3 million in Q1 2025.